industrial-biotechnology
(4)
Lishan Zhao Is Building Biotech for the Awkward Trip From Flask to Factory
After helping Amyris move engineered biology toward commercial products, the chemist founded Cataya around a stubborn lesson: a molecule matters only when the factory can make it reliably.
Paul Orlady Is Teaching Tiny Factories to Think Bigger
The economics graduate behind Khona Scientific is making a business case for microscopic order: line up the enzymes, simplify the supply chain, and let ordinary yeast attempt unusually complicated work.
Alan Shaw and the Food-from-Fuel Bet
A chemist who spent years trying to make fuel from plants found a more useful reversal: make protein from methane. Alan Shaw’s second biotech act is a lesson in recognizing the market hiding inside the science.
Douglas Friedman
Douglas Friedman is CEO of BioMADE, the U.S. Department of Defense-funded Manufacturing Innovation Institute dedicated to growing the domestic industrial biomanufacturing ecosystem. With a Ph.D. in Chemistry from Northwestern and a career spanning the National Academies, the White House OSTP, and the founding of the Engineering Biology Research Consortium, Friedman is one of the foremost architects of America's bioeconomy strategy — arguing that biology, not silicon, may define the next great manufacturing revolution.